Moderna finally cracks into gene editing with Metagenomi pact thanks to 'irresistible' data

We finally know who Moderna has been courting behind the scenes to make the big jump into gene editing. The famed biotech has signed a research partnership with CRISPR gene editing company Metagenomi.

Both parties are keeping mum on a lot of the details. We don’t know what indications they’ll go after, how many targets they will develop, how much Moderna will put up for research funding, how much was paid upfront, what the milestone or royalty payments will end up being down the line or how much of an equity investment Moderna made through the transaction.